Literature DB >> 7360428

Diagnostic and prognostic value of retinal hemorrhages in the neonate.

S Levin, J Janive, M Mintz, C Kreisler, M Romem, A Klutznik, M Feingold, V Insler.   

Abstract

Ocular fundi of 410 newborns were examined for retinal hemorrhages within 24 hours after delivery. The purpose of this study was to investigate whether the course of pregnancy and management of delivery influence the incidence of neonatal retinal hemorrhage (RH) and whether this incidence could be reduced by electronic monitoring of delivery. To assess the prognostic value of neonatal RH for future development of the child, the physical, motor, and psychologic states of 252 infants were examined 6 to 18 months following delivery. The incidence of RH was 37.3% and was not influenced by maternal age, parity, gestational age, course of pregnancy, birth weight, or electronic monitoring of delivery. The mode of delivery did influence the incidence of RH. Gesell developmental schedule showed no correlation between ocular findings and later development of the child.

Entities:  

Mesh:

Year:  1980        PMID: 7360428     DOI: 10.1097/00006250-198003000-00008

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.

Authors:  Ebenezer Daniel; Gui-Shuang Ying; R Michael Siatkowski; Wei Pan; Eli Smith; Graham E Quinn
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

Review 2.  Ocular pathology in shaken baby syndrome and other forms of infantile non-accidental head injury.

Authors:  Jakob Matschke; Klaus Püschel; Markus Glatzel
Journal:  Int J Legal Med       Date:  2008-10-21       Impact factor: 2.686

3.  Retinal hemorrhage in abusive head trauma: finding a common language.

Authors:  Alex V Levin; Jose A Cordovez; Benjamin E Leiby; Edward Pequignot; Anamika Tandon
Journal:  Trans Am Ophthalmol Soc       Date:  2014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.